Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisaftoclax + R-CHOP/Pola-R-CHP in Previously Untreated DLBCL
NCT07398638Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2026
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisaftoclax in diffuse large B-cell lymphoma (DLBCL), sponsored by Sun Yat-sen University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
lisaftoclax
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07398638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07398638.